Working Paper 05-19 - Lâ€™industrie pharmaceutique en Belgique - Analyse de compÃ©titivitÃ©
Bernadette Biatour and
Working Papers from Federal Planning Bureau, Belgium
This Working Paper analyses the competitive position of the pharmaceutical industry over the 2000-2017 period. The evolution of price/cost competitiveness and non-cost competitiveness is studied based on a comparison with our neighbouring countries France, the Netherlands and Germany, and with Denmark, Ireland, Slovenia and Switzerland. The study also analyses a series of global factors and factors specific to the pharmaceutical industry that may influence competitiveness.
JEL-codes: H32 O32 O38 O33 (search for similar items in EconPapers)
References: View complete reference list from CitEc
Citations: Track citations by RSS feed
Downloads: (external link)
https://www.plan.be/uploaded/documents/201905091117590.WP_1905_11895.pdf version franÃ§aise (application/pdf)
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
Persistent link: https://EconPapers.repec.org/RePEc:fpb:wpaper:1905
Access Statistics for this paper
More papers in Working Papers from Federal Planning Bureau, Belgium Contact information at EDIRC.
Bibliographic data for series maintained by Dominique van der Wal ().